ATE142620T1 - 1-alkyl-2-acyl-1,2-disulfonylhydrazine mit antineoplastischer aktivität - Google Patents

1-alkyl-2-acyl-1,2-disulfonylhydrazine mit antineoplastischer aktivität

Info

Publication number
ATE142620T1
ATE142620T1 AT92310041T AT92310041T ATE142620T1 AT E142620 T1 ATE142620 T1 AT E142620T1 AT 92310041 T AT92310041 T AT 92310041T AT 92310041 T AT92310041 T AT 92310041T AT E142620 T1 ATE142620 T1 AT E142620T1
Authority
AT
Austria
Prior art keywords
alkyl
acyl
disulfonylhydrazine
antineoplastic activity
antineoplastic
Prior art date
Application number
AT92310041T
Other languages
English (en)
Inventor
Alan C Sartorelli
Philip G Penketh
Krishnamurthy Shyam
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Application granted granted Critical
Publication of ATE142620T1 publication Critical patent/ATE142620T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/48—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom
    • C07C311/49—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom to nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92310041T 1991-11-08 1992-11-02 1-alkyl-2-acyl-1,2-disulfonylhydrazine mit antineoplastischer aktivität ATE142620T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/790,689 US5256820A (en) 1991-11-08 1991-11-08 1-alkyl-2-acyl-1,2-disulfonylhydrazines

Publications (1)

Publication Number Publication Date
ATE142620T1 true ATE142620T1 (de) 1996-09-15

Family

ID=25151476

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92310041T ATE142620T1 (de) 1991-11-08 1992-11-02 1-alkyl-2-acyl-1,2-disulfonylhydrazine mit antineoplastischer aktivität

Country Status (9)

Country Link
US (1) US5256820A (de)
EP (1) EP0541322B1 (de)
JP (1) JP3229039B2 (de)
AT (1) ATE142620T1 (de)
CA (1) CA2082037A1 (de)
DE (1) DE69213656T2 (de)
DK (1) DK0541322T3 (de)
ES (1) ES2094885T3 (de)
GR (1) GR3021045T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637619A (en) * 1995-07-05 1997-06-10 Yale University Antitumor 2-aminocarbonyl-1, 2-bis(methylsulfonyl)-1-(substituted)hydrazines
US6040338A (en) * 1997-11-03 2000-03-21 Yale University N,n-bis(sulfonyl)hydrazines useful as antineoplastic agents
WO2004098504A2 (en) * 2003-04-30 2004-11-18 Yale University Antitumor 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazines and methods of treating tumors
US6855695B2 (en) * 2003-06-13 2005-02-15 Vion Pharmaceuticals, Inc. Water-soluble SHPs as novel alkylating agents
US7605137B2 (en) * 2004-03-26 2009-10-20 Vion Pharmaceuticals, Inc. Combination therapy comprising cloretazine
WO2006034266A2 (en) * 2004-09-21 2006-03-30 Vion Pharmaceuticals, Inc. Sulfonyl hydrazines as hypoxia-selective antineoplastic agents
CN118994241B (zh) * 2023-05-17 2025-09-02 南京芩领医药科技有限公司 一类具有芳基酰胺结构的化合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684747A (en) * 1984-12-20 1987-08-04 Yale University N,N'-bis(sulfonyl)hydrazines having antineoplastic activity
US4892887A (en) * 1984-12-20 1990-01-09 Yale University N,N'-bis(sulfonyl)hydrazines having antineoplastic activity
US4849563A (en) * 1986-01-21 1989-07-18 Yale University Novel 1-alkyl-1-arenesulfonyl-2-alkoxycarbonylsulfenylhydrazines having antineoplastic activity
US5101072A (en) * 1989-09-06 1992-03-31 Yale University Sulfonylhydrazines and their use as antineoplastic agents and as antitrypanosomal agents

Also Published As

Publication number Publication date
JP3229039B2 (ja) 2001-11-12
JPH0625146A (ja) 1994-02-01
EP0541322A1 (de) 1993-05-12
DE69213656T2 (de) 1997-01-23
DE69213656D1 (de) 1996-10-17
DK0541322T3 (da) 1996-10-14
US5256820A (en) 1993-10-26
EP0541322B1 (de) 1996-09-11
CA2082037A1 (en) 1993-05-09
ES2094885T3 (es) 1997-02-01
GR3021045T3 (en) 1996-12-31

Similar Documents

Publication Publication Date Title
ATE116306T1 (de) Hypoglykämische oxazolidindion-derivate.
SG47986A1 (en) A pharmaceutical solution
ATE142630T1 (de) Triazin-derivate und unkrautvertilgungsmittel daraus
DE69325944D1 (de) s-Triazinderivate als Lichtschutzmittel
NO933376L (no) Morfinan-derivater og medisinsk anvendelse derav
FI914928A0 (fi) Hydroximetyl (metylencyklopentyl) puriner och -pyrimidiner.
DE69020287D1 (de) Pleuromutiline.
DK0382660T3 (da) Dioxaphosphorinanforbindelser og dermed stabiliserede polyolefinmaterialer
DE69213656D1 (de) 1-Alkyl-2-Acyl-1,2-Disulfonylhydrazine mit antineoplastischer Aktivität
ATE156486T1 (de) Fungizide 3,4-diaryl-(5h)-furan-2-onederivate
ATE155127T1 (de) Benzamid-derivate
AU597923B2 (en) 5-aminoalkyl-beta-carboline derivatives, their production and their use as drugs
ES2093051T3 (es) Purinil- y pirimidil-tetrahidrofuranos.
ATE60048T1 (de) Aminoverbindungen und diese enthaltende fungizide.
DE69314573D1 (de) 2-Thiazolylpyrroleakrylate mit fungizider Wirkung
PT88464A (pt) Process for the preparation of a macrolide compound

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee